FDA approves liver, gallbladder imaging software
The FDA has approved a new software imaging package to assist with the clinical diagnosis of liver and gallbladder diseases for distribution.
The system was co-developed by the physician husband-and-wife team of nuclear medicine specialists Gerbail T. and Shakuntala Krishnamurthy of Tuality Community Hospital in Hillsboro, Ore.
The recent FDA approval means that for the first time nuclear medicine departments will have access to universal standardized imaging of liver and gallbladder functions, according to L&G Medical Software, who will distribute the products.
The Krishnamurthy Hepatobiliary Software system, a PC-based program, is used for the diagnosis of acute and chronic liver disease (cirrhosis) and gallbladder diseases that reads and analyzes DICOM images from a gamma camera for analysis, the Portland, Ore.-based L&G said.
The system was co-developed by the physician husband-and-wife team of nuclear medicine specialists Gerbail T. and Shakuntala Krishnamurthy of Tuality Community Hospital in Hillsboro, Ore.
The recent FDA approval means that for the first time nuclear medicine departments will have access to universal standardized imaging of liver and gallbladder functions, according to L&G Medical Software, who will distribute the products.
The Krishnamurthy Hepatobiliary Software system, a PC-based program, is used for the diagnosis of acute and chronic liver disease (cirrhosis) and gallbladder diseases that reads and analyzes DICOM images from a gamma camera for analysis, the Portland, Ore.-based L&G said.